We are live on ! Find out more
WT

Washington Trust Portfolio holdings

AUM $2.96B
1-Year Est. Return 22.49%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+22.49%
3 Year Est. Return
+74.3%
5 Year Est. Return
+87.12%
10 Year Est. Return
+356.17%
AUM
$2.22B
AUM Growth
+$73.3M
Cap. Flow
-$48M
Cap. Flow %
-2.16%
Top 10 Hldgs %
30.47%
Holding
1,002
New
39
Increased
178
Reduced
234
Closed
52

Top Sells

Rank Stock Value
1
WSO icon
Watsco Inc
WSO
+$18.4M
2
HEI.A icon
HEICO Corp Class A
HEI.A
+$12.8M
3
ROP icon
Roper Technologies
ROP
+$8.94M
4
TFC icon
Truist Financial
TFC
+$8.29M
5
JPM icon
JPMorgan Chase
JPM
+$6.46M

Sector Composition

Rank Sector Weight
1 Technology 20.99%
2 Financials 11.36%
3 Healthcare 10.71%
4 Industrials 7.48%
5 Consumer Discretionary 7.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVRG icon
451
Evergy
EVRG
$19.7B
$39.5K ﹤0.01%
647
VGK icon
452
Vanguard FTSE Europe ETF
VGK
$30.2B
$39.2K ﹤0.01%
643
CAR icon
453
Avis
CAR
$5.88B
$39K ﹤0.01%
200
QQQJ icon
454
Invesco NASDAQ Next Gen 100 ETF
QQQJ
$1.12B
$38.7K ﹤0.01%
1,517
IWO icon
455
iShares Russell 2000 Growth ETF
IWO
$14.4B
$38.6K ﹤0.01%
+170
New +$38.9K
IR icon
456
Ingersoll Rand
IR
$33.9B
$38.5K ﹤0.01%
661
HSY icon
457
Hershey
HSY
$37.2B
$38.2K ﹤0.01%
150
KEY icon
458
KeyCorp
KEY
$24.3B
$37.6K ﹤0.01%
3,000
CHWY icon
459
Chewy
CHWY
$9.38B
$37.4K ﹤0.01%
+1,000
New +$41.4K
IVW icon
460
iShares S&P 500 Growth ETF
IVW
$71.9B
$37.1K ﹤0.01%
580
RVNC
461
DELISTED
Revance Therapeutics, Inc.
RVNC
$36.4K ﹤0.01%
+1,130
New +$35.2K
OGN icon
462
Organon & Co
OGN
$3.55B
$36.4K ﹤0.01%
1,547
-12
-0.8% -$322
CCI icon
463
Crown Castle
CCI
$33.1B
$36.3K ﹤0.01%
271
+5
+2% +$691
BP icon
464
BP
BP
$107B
$36K ﹤0.01%
948
-11
-1% -$411
BNDX icon
465
Vanguard Total International Bond ETF
BNDX
$82.3B
$35.6K ﹤0.01%
728
DVAX
466
DELISTED
Dynavax Technologies
DVAX
$35.3K ﹤0.01%
3,600
FBIN icon
467
Fortune Brands Innovations
FBIN
$6.09B
$35.2K ﹤0.01%
600
UA icon
468
Under Armour Class C
UA
$2.97B
$35.1K ﹤0.01%
4,116
CRSP icon
469
CRISPR Therapeutics
CRSP
$4.68B
$35.1K ﹤0.01%
775
MOG.B icon
470
Moog Inc Class B
MOG.B
$13.6B
$34.8K ﹤0.01%
351
ALB icon
471
Albemarle
ALB
$13.3B
$34.7K ﹤0.01%
157
SCHG icon
472
Schwab US Large-Cap Growth ETF
SCHG
$59.1B
$34.5K ﹤0.01%
2,120
IT icon
473
Gartner
IT
$10.4B
$34.5K ﹤0.01%
106
VOE icon
474
Vanguard Mid-Cap Value ETF
VOE
$24.1B
$34.2K ﹤0.01%
255
IVE icon
475
iShares S&P 500 Value ETF
IVE
$49.6B
$34.1K ﹤0.01%
225

Similar funds

Washington Trust's Q1 2023 Portfolio in Review

As of Q1 2023, Washington Trust held 1,002 positions worth $2.22B, up 3.4% from $2.15B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Washington Trust's Q1 2023 filing shows 39 new, 178 increased, 234 reduced and 52 closed positions. Its largest new stake was iShares US Healthcare ETF: 2,980 shares worth $163K. The largest sale was Watsco Inc, an estimated $18.4M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.

  • Washington Trust's largest Q1 2023 buy was iShares US Healthcare ETF: 2,980 shares worth $163K.
  • Washington Trust added most to iShares US Financials ETF in Q1 2023, an estimated $4.68M increase.
  • Washington Trust's biggest Q1 2023 reduction was Watsco Inc, cutting an estimated $18.4M.
  • Washington Trust fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $1.4M.
  • Washington Trust's ten largest holdings make up 30% of its $2.22B portfolio in Q1 2023.
  • Washington Trust opened 39 new positions and closed 52 in Q1 2023.
  • Washington Trust's portfolio value rose 3.4% quarter-over-quarter to $2.22B.

Based on Washington Trust's 13F filing for Q1 2023, filed 4 May 2023.